The Procter Gamble Company

Thomas W Gibson

Richard S Echler

Thomas L Cupps

Joseph H Gardner

Gerald B Kasting

Joel I Shulman

The subject invention relates to a process for the preparation of 2-alkyl-4-acyl-6-tert-butylphenol compound having the chemical structure: ##STR1## wherein -R is an aliphatic group having a terminally unsaturated moiety selected from --C.tbd.CH and --CH.dbd.C.dbd.CH.sub.2, and R' is selected from saturated, straight, branched or cyclic alkyl having from 1 to about 10 carbon atoms; the 2-alkyl-4-acyl-6-tert-butylphenol compound being produced in a reaction mixture comprising the corresponding 2-alkyl-6-tert-butylphenol: ##STR2## the corresponding carboxylic acid: RCOOH, and trifluoroacetic anhydride.

Process for the preparation of 2-alkyl-4-acyl-6-tert-butylphenol

The present invention relates to beta-aminoethyl-substituted phenyl compounds, especially beta-aminoethoxy-substituted phenyl compounds. The present invention also relates to pharmaceutical compositions comprising a safe and effective amount of a compound of the present invention and a pharmaceutically-acceptable carrier. The present invention further relates to methods for producing analgesia and reducing inflammation, in humans and lower animals, by administering the compounds or compositions of the present invention. In addition, the present invention relates to methods for making compounds of the present invention and intermediates useful in these synthesis methods.

Novel compounds, pharmaceutical compositions, and methods for treating

A process for preparing primary substituted n-alkane compounds, comprising contacting the olefin product of an olefin metathesis reaction having an alpha-olefin as the reactant with a bis-cyclopentadienyl zirconium hydrohalide and, after contacting the product of the olefin-zirconium hydrohalide reaction with an electrophilic reagent, recovering said primary substituted n-alkane compound.

Growing community of inventors

Cincinnati, OH, United States of America

Thomas W Gibson